New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Neuronetics, Inc.
STIM
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

35M

Medical - Diagnostics & Research

Next Earning date - 12 Nov 2024

35M

Medical - Diagnostics & Research

Next Earning date - 12 Nov 2024

1.17USD
Shape0.09Ā ( 8.33%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-55%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

77%

Quote Panel

Shape
Updated November 9, 2024
1W 7.34 % 1M 36.05 % 3M 57.05 % 1Y -7.87 %

Key Metrics

Shape
  • Market Cap

    35.46M


  • Shares Outstanding

    30.31M


  • Share in Float

    27.98M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    1.17


  • Average Volume

    438464


  • Beta

    2.216


  • Range

    0.664-5.07


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.neurostar.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.49x

P/S Ratio

1.81x

P/B Ratio

3.1

Debt/Equity

-45.1%

Net Margin

$-1.1

EPS

How STIM compares to sector?

P/E Ratio

Relative Strength

Shape

STIM

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$87M

Shape431%

2025-Revenue

$0.63

Shape-90%

2025-EPS

$38M

Shape-376%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

William Blair

downgrade

Previous: Outperform

2024-08-12

Now: Market Perform

William Blair

upgrade

Previous: Not converted

2024-05-14

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.28
vsĀ -0.31

Q4.22

arrow
arrow

N/A

-0.30
vsĀ -0.29

Q1.23

arrow
arrow

N/A

-0.38
vsĀ -0.41

Q2.23

arrow
arrow

N/A

-0.17
vsĀ -0.39

Q3.23

arrow
arrow

N/A

-0.33
vsĀ -0.28

Q4.23

arrow
arrow

N/A

-0.19
vsĀ -0.30

Q1.24

arrow
arrow

N/A

-0.27
vsĀ -0.38

Q2.24

arrow
arrow

N/A

-0.33
vsĀ -0.17

Q3.24

arrow
arrow

N/A

-0.23
vsĀ -0.33

Q4.24

arrow
arrow

N/A

-0.07
vsĀ -0.19

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+20%

16.5MĀ  vsĀ 13.8M

Q4.22

arrow
arrow

+21%

18.2MĀ  vsĀ 15M

Q1.23

arrow
arrow

+10%

15.5MĀ  vsĀ 14.2M

Q2.23

arrow
arrow

+8%

17.6MĀ  vsĀ 16.3M

Q3.23

arrow
arrow

+8%

17.9MĀ  vsĀ 16.5M

Q4.23

arrow
arrow

+12%

20.3MĀ  vsĀ 18.2M

Q1.24

arrow
arrow

+12%

17.4MĀ  vsĀ 15.5M

Q2.24

arrow
arrow

-7%

16.4MĀ  vsĀ 17.6M

Q3.24

arrow
arrow

+7%

19.1MĀ  vsĀ 17.9M

Q4.24

arrow
arrow

+23%

24.9MĀ  vsĀ 20.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-12%

-0.12
vsĀ -0.15

Q4.22

arrow
arrow

-16%

-0.16
vsĀ -0.12

Q1.23

arrow
arrow

-23%

-0.23
vsĀ -0.16

Q2.23

arrow
arrow

-11%

-0.11
vsĀ -0.23

Q3.23

arrow
arrow

-25%

-0.25
vsĀ -0.11

Q4.23

arrow
arrow

-16%

-0.16
vsĀ -0.25

Q1.24

arrow
arrow

-28%

-0.28
vsĀ -0.16

Q2.24

arrow
arrow

-51%

-0.51
vsĀ -0.28

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

74

74
vsĀ 73

1%

Q4.22

arrow
arrow

86

86
vsĀ 74

16%

Q1.23

arrow
arrow

76

76
vsĀ 86

-12%

Q2.23

arrow
arrow

71

71
vsĀ 76

-7%

Q3.23

arrow
arrow

57

57
vsĀ 71

-20%

Q4.23

arrow
arrow

67

67
vsĀ 57

18%

Q1.24

arrow
arrow

67

67
vsĀ 67

NA

Q2.24

arrow
arrow

66

66
vsĀ 67

-1%

Earnings Growth

Latest News